Fumaderm (dimethyl fumarate) / Biogen  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fumaderm (dimethyl fumarate) / Biogen
2011-000659-18: Treatment of therapy resistant Alopecia areata with fumaric acid esters (Fumaderm® and Fumaderm initial®) – an open, single center, non-randomized, pilot study with 40 patients

Ongoing
2
40
Europe
Fumaderm, Fumaderm initial, Tablet, Fumaderm, Fumaderm initial
University Hospital Tübingen, Biogen Idec
Alopecia areata, Alopecia arata, Body processes [G] - Immune system processes [G12]
 
 

Download Options